Nano Science and Technology Institute - NSTI  
Nano Science and Technology Institute   Home | Subscribe | Site Map  
  ABOUT | COURSES | EVENTS | PUBLICATIONS | LEADERSHIP | OUTREACH | NEWS | PRESS | JOBS | Nanotechnology Solutions
px
px fade_top
Publications
Nanotech 2008 CDROM
Nanotech 2007 CDROM
Nanotech 2006 CDROM
Nanotech 2005 CDROM
Nanotech 2004 CDROM
3 CDROM Special Offer
Nanotech 2008 Vol. 1
Nanotech 2008 Vol. 2
Nanotech 2008 Vol. 3
Nanotech 2007 Vol. 1
Nanotech 2007 Vol. 2
Nanotech 2007 Vol. 3
Nanotech 2007 Vol. 4
Nanotech 2006 Vol. 1
Nanotech 2006 Vol. 2
Nanotech 2006 Vol. 3
Nanotech 2005 Vol. 1
Nanotech 2005 Vol. 2
Nanotech 2005 Vol. 3
WCM 2005
Nanotech 2004 Vol. 1
Nanotech 2004 Vol. 2
Nanotech 2004 Vol. 3
Nanotech 2003 Vol. 1
Nanotech 2003 Vol. 2
Nanotech 2003 Vol. 3
Nanotech 2002 Vol. 1
Nanotech 2002 Vol. 2
Nanotech 2001 Vol. 1
Nanotech 2001 Vol. 2
MSM 2000
MSM 99
MSM 98
Index of Authors
Index of Keywords
Index of Affiliations
Library Request Form
Shopping Cart
Order Form
 
Publications Publications
Nanotech 2006 Vol. 2
p
 
Technical Proceedings of the 2006 NSTI Nanotechnology Conference and Trade Show, Volume 2
Nanotech 2006 Vol. 2
Technical Proceedings of the 2006 NSTI Nanotechnology Conference and Trade Show, Volume 2
 
Chapter 1: Cancer Nanotechnology
 

Nano-Mesosphere Drug Carriers for Localized Cancer Chemotherapy

Authors:E.P. Goldberg, B.A. Almond, A.R. Hadba, B.J Cuevas, A. York, I. Enriquez
Affilation:University of Florida, US
Pages:1 - 4
Keywords:local chemotherapy, nano-mesospheres, intratumoral therapy
Abstract:Aggressive conventional chemotherapy of solid cancers of the breast, lung, prostate, and colorectal area is severely limited by systemic toxic complications. New clinically practical concepts are needed for effective local therapeutic modalities. This paper reports recent preclinical studies using direct intratumoral injection of nano-mesoparticulate drug carriers in animal models of lung and breast adenocarcinomas with metastasis. Data for protein (albumin or casein) particles containing >15 wt% mitoxantrone is presented showing greatly prolonged survival (>300%); with possible “cures” when a neoadjuvant treatment is use (with surgical resection of necrotic tumor within 7-10 days of IT treatment). Clinical studies, especially for tissue-conserving neoadjuvant chemotherapy, may be warranted.
ISBN:0-9767985-7-3
Pages:893
Hardcopy:$185.00
 
Order:Mail/Fax Form
Special:3 CD Set — 15% off with Free Shipping
Up
nanoPRwire™
nanoPRwire
News Headlines
nano World news
 
 
 
 
px
© Nano Science and Technology Institute     About NSTI | Terms of Use | Privacy Policy | Contact